Sponsors & Exhibitors

Moderna

In 10 years since its inception, Moderna has transformed from a research-stage company advancing programs in the field of messenger RNA (mRNA), to an enterprise with a diverse clinical portfolio of vaccines and therapeutics across seven modalities, a broad intellectual property portfolio in areas including mRNA and lipid nanoparticle formulation, and an integrated manufacturing plant that allows for rapid clinical and commercial production at scale.

Moderna’s mRNA platform builds on continuous advances in basic and applied mRNA science, delivery technology and manufacturing, and has allowed the development of therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. To learn more, visit www.modernatx.com.

Takeda

As a leading values-based, R&D-driven biopharmaceutical company headquartered in Tokyo, with a global hub in Massachusetts, Takeda is committed to bringing better health and a brighter future to patients by translating science into highly innovative medicines and vaccines. For more than 70 years, we have supplied routine vaccines to protect the health of people in Japan including measles, rubella, and mumps. Today, we’re expanding our global vaccine business by applying innovation to tackle some of the world’s most challenging infectious diseases, such as dengue, COVID-19, pandemic influenza and Zika. Our team brings an outstanding track record and a wealth of knowledge in global vaccine development and manufacturing to advance a pipeline of vaccines to address some of the most pressing public health needs. Our mission is to develop and deliver innovative vaccines that tackle some of the toughest problems in public health and improve the lives of people around the world.

MSD

At MSD, known as Merck & Co., Inc., Rahway, NJ, USA in the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than 130 years, we have brought hope to humanity through the development of important medicines and vaccines. We aspire to be the premier research-intensive biopharmaceutical company in the world – and today, we are at the forefront of research to deliver innovative health solutions that advance the prevention and treatment of diseases in people and animals. We foster a diverse and inclusive global workforce and operate responsibly every day to enable a safe, sustainable and healthy future for all people and communities. 

For more information, visit www.msd.com and connect with us on Twitter, LinkedIn and YouTube. 

GSK

GSK Purpose, strategy and culture.  

We are a global biopharma company with a purpose to unite science, technology and talent to get ahead of disease together. 

We aim to positively impact the health of 2.5 billion people by the end of 2030. Our bold ambitions for patients are reflected in new commitments to growth and a step-change in performance. 

We are a company where outstanding people can thrive. 

Learn more about GSK (www.gsk.com)

Novavax

Novavax, Inc. is a global biotechnology company committed to helping address serious infectious diseases globally through the discovery, development, and delivery of innovative vaccines to patients around the world.

Our commitment is backed by solid science tested by decades of research, vaccines developed from trusted technology and a global network that will help to ensure our vaccines reach everyone who needs them.

NUVAXOVID is a unique COVID-19 vaccine that combines a proprietary Matrix-M adjuvant with a protein subunit platform used in some vaccines for influenza, hepatitis B, and HPV.

NUVAXOVID is indicated for active immunization to prevent COVID-19 caused by SARS-CoV-2 in individuals 12 years of age and older.

Sanofi

Sanofi is an innovative global healthcare company, driven by one purpose: we chase the miracles of science to improve people’s lives. Our team, across some 100 countries, is dedicated to transforming the practice of medicine by working to turn the impossible into the possible. We provide potentially life-changing treatment options and life-saving vaccine protection to millions of people globally, while putting sustainability and social responsibility at the center of our ambitions. For more information, visit  www.sanofi.com